Titre:
  • Gene expression signatures can predict the efficacy of anthracyclines in HER2-negative and HER-2 positive breast cancer (BC) patients: the results of the TOP trial and their validation in the BIG 1-00 trial, on behalf of the TOP trial investigators.
Auteur:Desmedt, Christine; Haibe-Kains, Benjamin; Azambuja, Evandro; Larsimont, Denis; Delaloge, Suzette; Duhem, Caroline; Di Leo, Angelo; D'Hondt, Veronique; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:IMPAKT Breast Cancer Conference (May 7-9, 2009: Brussels, Belgium)
Statut de publication:Non publié, 2009-05
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Langue:Anglais